Naoki Kohira

<i>In Vitro</i> Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

Akinobu Ito, Takafumi Sato, Merime Ota et al. · Antimicrobial Agents and Chemotherapy · 2017 · 356 citations · Full text

<i>In Vitro</i> Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains

Naoki Kohira, Joshua M. West, Akinobu Ito et al. · Antimicrobial Agents and Chemotherapy · 2015 · 238 citations · Full text

<i>In vitro</i>antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Akinobu Ito, Naoki Kohira, Samuel K. Bouchillon et al. · Journal of Antimicrobial Chemotherapy · 2015 · 183 citations · Full text

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

Naoki Kohira, Meredith Hackel, Yoshino Ishioka et al. · Journal of Global Antimicrobial Resistance · 2020 · 102 citations · Full text

Gene cloning and characteristics of the RND-type multidrug efflux pump MuxABC-OpmB possessing two RND components in Pseudomonas aeruginosa

Takehiko Mima, Naoki Kohira, Yang Li et al. · Microbiology · 2009 · 74 citations